FDA approves a CRISPR-based medicine for treatment of sickle cell disease- In historic decision

New Drug That Could Extend Dogs' Lives Gets Closer to FDA Approval

The lucky break behind the first CRISPR treatment. Gene editing for sickle-cell is here. This is how researchers knew what DNA to change.

CRISPR 2.0: a new wave of gene editors heads for clinical trials